logo

For the Inventor, By the Inventor

Chestnut Hill, MA, United States of America

Kenneth L Rock

This inventor holds 19 USPTO granted patents and 3 published patent applications, primarily in Immunotherapy Research. Top assignees: University of Massachusetts, Dana-Farber-Cancer Institute Inc., Corixa Corporation. Active years: 1994-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth L Rock. Retrieved from https://idiyas.com/inventor/kenneth-l-rock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 47.4

Average Co-Inventor Count = 1.5

ph-index = 6

Forward Citations = 236(Granted Patents)


Location History:

  • Tallmadge, OH (US) (2007 - 2009)
  • Chestnut Hill, MA (US) (1994 - 2013)

Company Filing History:

goldMedal10 out of 1,630 
 
University of Massachusetts
 patents
silverMedal5 out of 1,268 
 
Dana-Farber-Cancer Institute Inc.
 patents
bronzeMedal2 out of 247 
 
Corixa Corporation
 patents
4. 2 out of 1,962 
 
University of Pittsburgh
 patents
5. 2 out of 9 
 
Waltco Truck Equipment Company
 patents
6. 2 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2013

Loading Chart...
Areas of Expertise:
Antitumor Antibodies
Immune Response
Sterile Inflammation
Cytotoxic T Lymphocytes
Genetic Immunization
Protein Antigens
Exogenous Peptides
MHC Class I
Adjuvant Molecules
Cancer Treatment
Immunization Methods
Targeted Therapy
19 patents (USPTO):Explore Patents
1. 8597664 - Endogenous adjuvant molecules and uses thereof (2013-12-03),
2. 8444972 - Antitumor antibodies, proteins, and uses thereof (2013-05-21),
3. 8101586 - Methods and compositions for the treatment of sterile inflammation (2012-01-24),
4. 7935338 - Antibodies to treat cancer (2011-05-03),
5. 7902339 - Antitumor antibodies, proteins, and uses thereof (2011-03-08),
6. 7807187 - Endogenous adjuvant molecules and uses thereof (2010-10-05),
7. 7781569 - Antibodies to treat cancer (2010-08-24),
8. 7781212 - Antitumor antibodies, proteins, and uses thereof (2010-08-24),
9. 7736860 - Methods of identifying compounds for the treatment of sterile inflammation (2010-06-15),
10. 7604267 - Modular dock bumper (2009-10-20),
11. 7573221 - Wireless liftgate control system (2009-08-11),
12. 7186137 - Coiled charging cable (2007-03-06),
13. 7176186 - Stimulation of cell-mediated immune responses by targeted particulate genetic immunization (2007-02-13),
14. 6693176 - Antitumor antibodies, proteins, and uses thereof (2004-02-17),
15. 6328972 - Compositions and methods for inducing cytotoxic T lymphocyte responses by immunization with protein antigens (2001-12-11),

Title: The Inventor Kenneth L Rock: Pioneering Innovations in Chestnut Hill

Introduction: Kenneth L Rock is a distinguished inventor based in Chestnut Hill, MA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Kenneth L Rock's latest patents include cutting-edge technologies in the fields of renewable energy, medical devices, and artificial intelligence, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Kenneth L Rock has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible.

Collaborations: Throughout his career, Kenneth L Rock has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Kenneth L Rock's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor, shaping the future of technology and leaving a lasting impact on the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…